03/26/2024 4:00 PM | Harvard Bioscience (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/19/2024 12:02 PM | Harvard Bioscience (Subject) Leviticus Partners LP (Filed by)
| Form SC 13G | |
03/07/2024 6:00 AM | Harvard Bioscience (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 7:46 AM | B. Riley Asset Management, LLC (Filed by) Harvard Bioscience (Subject)
| Form SC 13G/A | |
01/26/2024 4:26 PM | BlackRock Inc. (Filed by) Harvard Bioscience (Subject)
| Form SC 13G | |
01/22/2024 9:55 AM | Harvard Bioscience (Subject) Leviticus Partners LP (Filed by)
| Form SC 13G/A | |
01/05/2024 4:01 PM | Harvard Bioscience (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/03/2024 4:17 PM | Cote Jennifer (Reporting) Harvard Bioscience (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 4:18 PM | Green James W (Reporting) Harvard Bioscience (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2023 3:45 PM | Harvard Bioscience (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023 6:00 AM | Harvard Bioscience (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/28/2023 2:07 PM | Harvard Bioscience (Subject) Leviticus Partners LP (Filed by)
| Form SC 13G | |
08/08/2023 8:05 AM | Harvard Bioscience (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/20/2023 7:15 AM | Harvard Bioscience (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/13/2023 3:02 PM | Green James W (Reporting) Harvard Bioscience (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2023 3:17 PM | Harvard Bioscience (Filer)
| Form SD Specialized Disclosure Report | |
05/23/2023 3:03 PM | Harvard Bioscience (Issuer) LOY BERTRAND (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2023 3:04 PM | Harvard Bioscience (Issuer) Loewald Thomas W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2023 3:07 PM | Eade Katherine A. (Reporting) Harvard Bioscience (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/25/2023 7:00 AM | Harvard Bioscience (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/07/2023 3:31 PM | Harvard Bioscience (Filer)
| Form ARS | |
04/05/2023 7:30 AM | Harvard Bioscience (Filer)
| Form DEF 14A | |